TRIHEXYPHENIDYL HYDROCHLORIDE

TRIHEXYPHENIDYL HYDROCHLORIDE was reported 1019 times

TRIHEXYPHENIDYL HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MACROPROLACTINAEMIA 2 0.2222
1 STATUS DYSTONICUS 2 0.1333
2 TYROSINAEMIA 1 0.0833
3 RED BLOOD CELL MICROCYTES PRESENT 1 0.0667
4 CEREBRAL ARTERY THROMBOSIS 33 0.0642
5 DOPAMINE SUPERSENSITIVITY PSYCHOSIS 1 0.0625
6 BRAIN SCAN ABNORMAL 34 0.0609
7 COMPUTERISED TOMOGRAM KIDNEY ABNORMAL 1 0.0556
8 RED BLOOD CELL HYPOCHROMIC MORPHOLOGY PRESENT 1 0.0556
9 GLABELLAR REFLEX ABNORMAL 1 0.0526
10 COGNITIVE LINGUISTIC DEFICIT 1 0.0385
11 FAILURE TO SUSPEND MEDICATION 7 0.0338
12 PRODUCT ADMINISTRATION ISSUE 7 0.0335
13 RED BLOOD CELL MACROCYTES PRESENT 1 0.0323
14 WRONG PATIENT 15 0.0299
15 IDIOPATHIC PANCREATITIS 1 0.0278
16 ORTHOSTATIC TREMOR 1 0.0238
17 DISTAL INTESTINAL OBSTRUCTION SYNDROME 8 0.0237
18 POSTURAL REFLEX IMPAIRMENT 1 0.0192
19 RESTLESS ARM SYNDROME 3 0.0192
20 VON WILLEBRAND'S DISEASE 1 0.0182
21 WRONG DRUG 7 0.0181
22 PLATELET AGGREGATION DECREASED 1 0.0132
23 AREFLEXIA 35 0.0131
24 SCIATIC NERVE PALSY 1 0.0122
25 DYSKINESIA OESOPHAGEAL 1 0.0112
26 SOMATIC HALLUCINATION 1 0.0111
27 PENILE ABSCESS 1 0.0108
28 VENTRICULAR INTERNAL DIAMETER ABNORMAL 1 0.0105
29 CSF GLUCOSE INCREASED 1 0.0104
30 CHORDAE TENDINAE RUPTURE 1 0.0102
31 WOUND EVISCERATION 1 0.0102
32 BRONCHOPULMONARY DISEASE 1 0.0101
33 LYMPHOCYTE PERCENTAGE INCREASED 4 0.0099
34 GENITAL CYST 1 0.0096
35 WRONG PATIENT RECEIVED PRODUCT 25 0.0085
36 HYPERSENSITIVITY MYOCARDITIS 1 0.0083
37 FAECALITH 1 0.0083
38 ABDOMINAL WALL MASS 1 0.0082
39 GENITAL NEOPLASM MALIGNANT FEMALE 1 0.0081
40 PORTAL TRACT INFLAMMATION 1 0.0079
41 TRANSIENT APHASIA 1 0.0076
42 DELUSION OF REFERENCE 1 0.0072
43 CRUSH SYNDROME 1 0.0071
44 JEALOUS DELUSION 2 0.0071
45 TOTAL BILE ACIDS INCREASED 1 0.0068
46 PERIPANCREATIC FLUID COLLECTION 1 0.0066
47 COSTOVERTEBRAL ANGLE TENDERNESS 1 0.0061
48 RABBIT SYNDROME 1 0.0060
49 DECREASED GAIT VELOCITY 1 0.0060
50 HIGH ARCHED PALATE 1 0.0058
51 INFUSION SITE INJURY 1 0.0057
52 PARKINSONISM HYPERPYREXIA SYNDROME 1 0.0056
53 DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA 1 0.0055
54 PROTHROMBIN LEVEL DECREASED 5 0.0053
55 GRANULOCYTOSIS 1 0.0051
56 POSTOPERATIVE DELIRIUM 1 0.0051
57 PANCREATIC ABSCESS 1 0.0050
58 DIVERTICULAR PERFORATION 10 0.0049
59 PNEUMOCONIOSIS 1 0.0048
60 PIERRE ROBIN SYNDROME 1 0.0047
61 GLOSSOPTOSIS 1 0.0046
62 HIP DYSPLASIA 1 0.0045
63 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0044
64 POST PROCEDURAL PULMONARY EMBOLISM 1 0.0043
65 DYSLALIA 3 0.0041
66 DILATED CARDIOMYOPATHY 4 0.0040
67 NECROTISING COLITIS 5 0.0039
68 METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS 1 0.0039
69 HEMIPLEGIA 32 0.0038
70 MALIGNANT CATATONIA 1 0.0038
71 BASOPHIL COUNT DECREASED 1 0.0038
72 ACCIDENTAL DEATH 7 0.0038
73 FACIAL PARALYSIS 32 0.0038
74 COAGULATION FACTOR DECREASED 1 0.0037
75 MEDICAL DEVICE SITE HAEMORRHAGE 1 0.0035
76 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1 0.0035
77 CORONARY ARTERY DISSECTION 3 0.0035
78 SOLILOQUY 3 0.0035
79 CEREBELLAR ATROPHY 3 0.0034
80 SUBILEUS 7 0.0034
81 PARKINSONIAN GAIT 2 0.0032
82 ABDOMINAL COMPARTMENT SYNDROME 2 0.0031
83 CATHETER SITE IRRITATION 1 0.0030
84 HEAT ILLNESS 2 0.0030
85 CHOREA 5 0.0029
86 SEPTIC ARTHRITIS STAPHYLOCOCCAL 1 0.0029
87 TORTICOLLIS 6 0.0028
88 IDIOPATHIC INTERSTITIAL PNEUMONIA 1 0.0028
89 ESCHERICHIA URINARY TRACT INFECTION 12 0.0028
90 HEPATITIS B VIRUS TEST POSITIVE 1 0.0026
91 STOMA SITE EXTRAVASATION 1 0.0026
92 HUMIDITY INTOLERANCE 1 0.0025
93 VITAMIN K DEFICIENCY 1 0.0025
94 CHRONIC HEPATITIS 2 0.0025
95 MASKED FACIES 1 0.0025
96 ISCHAEMIC STROKE 44 0.0025
97 BLOOD URIC ACID ABNORMAL 1 0.0025
98 NORMAL PRESSURE HYDROCEPHALUS 1 0.0024
99 GASTRODUODENAL ULCER 1 0.0024
100 VITAMIN B1 DEFICIENCY 1 0.0023
101 SELF-DESTRUCTIVE BEHAVIOUR 2 0.0023
102 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 2 0.0022
103 PERINEAL ABSCESS 1 0.0022
104 EXTRAOCULAR MUSCLE PARESIS 1 0.0022
105 LOCKED-IN SYNDROME 1 0.0022
106 SUDDEN ONSET OF SLEEP 3 0.0022
107 SEXUALLY INAPPROPRIATE BEHAVIOUR 1 0.0021
108 NEUROLEPTIC MALIGNANT SYNDROME 25 0.0021
109 INFUSION SITE HAEMATOMA 1 0.0021
110 HYPERGAMMAGLOBULINAEMIA 1 0.0021
111 BLOOD URIC ACID DECREASED 1 0.0021
112 EAR INJURY 1 0.0020
113 VISCERAL CONGESTION 1 0.0020
114 PARKINSONISM 19 0.0019
115 HYPERTROPHIC CARDIOMYOPATHY 3 0.0019
116 COLITIS ISCHAEMIC 13 0.0019
117 WRONG PRODUCT ADMINISTERED 13 0.0019
118 SALIVARY HYPERSECRETION 19 0.0019
119 INFUSION SITE CELLULITIS 1 0.0019
120 ASTERIXIS 2 0.0019
121 FAECAL VOMITING 1 0.0019
122 NEUTROPHIL PERCENTAGE DECREASED 1 0.0019
123 JOINT CONTRACTURE 2 0.0019
124 OESOPHAGEAL FOOD IMPACTION 1 0.0018
125 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 1 0.0018
126 MEDICAL DEVICE SITE PAIN 1 0.0018
127 METAL POISONING 1 0.0017
128 URINARY TRACT INFECTION PSEUDOMONAL 1 0.0017
129 BEHAVIOUR DISORDER 9 0.0017
130 NEUROPSYCHOLOGICAL SYMPTOMS 1 0.0017
131 BLOOD VISCOSITY INCREASED 1 0.0017
132 PITTING OEDEMA 1 0.0016
133 MONOCYTOSIS 1 0.0016
134 BLOOD UREA DECREASED 2 0.0016
135 PERSECUTORY DELUSION 4 0.0016
136 GLOMERULOSCLEROSIS 1 0.0016
137 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 1 0.0016
138 RESPIRATORY DISTRESS 43 0.0016
139 POSTURE ABNORMAL 5 0.0015
140 ANISOCYTOSIS 1 0.0015
141 CATATONIA 8 0.0015
142 COMPULSIONS 1 0.0015
143 LYMPHOCYTE PERCENTAGE DECREASED 2 0.0015
144 HYPOVOLAEMIC SHOCK 7 0.0015
145 NUTRITIONAL CONDITION ABNORMAL 1 0.0014
146 ANTIPSYCHOTIC DRUG LEVEL INCREASED 4 0.0014
147 FOETAL HEART RATE DECELERATION ABNORMALITY 1 0.0014
148 INFUSION SITE INFLAMMATION 1 0.0014
149 BORDERLINE PERSONALITY DISORDER 1 0.0014
150 PNEUMONIA ASPIRATION 35 0.0014
151 OCULOGYRIC CRISIS 3 0.0014
152 APALLIC SYNDROME 1 0.0014
153 OROMANDIBULAR DYSTONIA 1 0.0014
154 STOMA SITE PAIN 2 0.0014
155 AMINO ACID LEVEL INCREASED 1 0.0013
156 HYPERTHERMIA MALIGNANT 2 0.0013
157 STOMA SITE INFLAMMATION 1 0.0013
158 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
159 ANOSOGNOSIA 1 0.0013
160 MUSCLE DISCOMFORT 1 0.0013
161 LABORATORY TEST INTERFERENCE 1 0.0013
162 RETINAL PIGMENTATION 1 0.0013
163 RETROGRADE EJACULATION 1 0.0013
164 ON AND OFF PHENOMENON 7 0.0013
165 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 1 0.0013
166 ANTICHOLINERGIC SYNDROME 2 0.0013
167 VITAMIN B12 INCREASED 1 0.0013
168 THYROID HORMONES DECREASED 1 0.0013
169 EXTRAPYRAMIDAL DISORDER 31 0.0012
170 TUMOUR EXCISION 1 0.0012
171 ABDOMINAL SYMPTOM 1 0.0012
172 ANTICONVULSANT DRUG LEVEL INCREASED 2 0.0012
173 SCHIZOPHRENIA 15 0.0012
174 DYSBIOSIS 1 0.0012
175 LEUKOCYTURIA 1 0.0012
176 CSF PROTEIN INCREASED 1 0.0012
177 HYPERNATRAEMIA 6 0.0012
178 MEAN PLATELET VOLUME DECREASED 1 0.0012
179 DEVICE LOOSENING 1 0.0012
180 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
181 FOOD REFUSAL 1 0.0011
182 HYPERPLASIA 1 0.0011
183 ALTERED STATE OF CONSCIOUSNESS 24 0.0011
184 PLEUROTHOTONUS 1 0.0011
185 DEVICE ALARM ISSUE 2 0.0011
186 FAECALOMA 6 0.0011
187 ABULIA 1 0.0011
188 HEPATITIS ACUTE 7 0.0011
189 STOMA SITE ERYTHEMA 2 0.0011
190 APPLICATION SITE DERMATITIS 1 0.0011
191 COMA 50 0.0010
192 COR PULMONALE 1 0.0010
193 CEREBELLAR ATAXIA 1 0.0010
194 CARDIOPULMONARY FAILURE 4 0.0010
195 HYPERTRIGLYCERIDAEMIA 6 0.0010
196 PYELONEPHRITIS ACUTE 2 0.0010
197 SPUTUM RETENTION 1 0.0010
198 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 1 0.0010
199 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
200 BREAST ABSCESS 1 0.0010
201 AKINESIA 2 0.0010
202 FEEDING DISORDER NEONATAL 1 0.0010
203 COGWHEEL RIGIDITY 1 0.0010
204 OEDEMA MUCOSAL 1 0.0010
205 POISONING DELIBERATE 9 0.0009
206 MUSCLE RIGIDITY 11 0.0009
207 PRODUCT NAME CONFUSION 1 0.0009
208 ACINETOBACTER INFECTION 1 0.0009
209 LIPASE INCREASED 7 0.0009
210 INFUSION SITE HAEMORRHAGE 3 0.0009
211 DELUSION 14 0.0009
212 ESSENTIAL TREMOR 1 0.0009
213 OPEN WOUND 1 0.0009
214 GASTROINTESTINAL HYPOMOTILITY 2 0.0009
215 DYSTONIA 17 0.0009
216 DISTRACTIBILITY 1 0.0009
217 INFUSION SITE INFECTION 2 0.0009
218 DILATATION ATRIAL 1 0.0009
219 HYPORESPONSIVE TO STIMULI 1 0.0009
220 SENSE OF OPPRESSION 1 0.0008
221 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
222 ESCHERICHIA TEST POSITIVE 1 0.0008
223 CARDIAC DEATH 1 0.0008
224 MONOCYTE COUNT DECREASED 1 0.0008
225 INFUSION SITE WARMTH 1 0.0008
226 PSYCHIATRIC SYMPTOM 6 0.0008
227 VICTIM OF CRIME 1 0.0008
228 POISONING 10 0.0008
229 FRACTURED COCCYX 1 0.0008
230 MALLORY-WEISS SYNDROME 1 0.0008
231 FOREIGN BODY IN RESPIRATORY TRACT 1 0.0008
232 BEZOAR 1 0.0007
233 BRONCHIAL OBSTRUCTION 1 0.0007
234 GRANULOCYTOPENIA 4 0.0007
235 CEREBELLAR HAEMORRHAGE 1 0.0007
236 DISEASE RECURRENCE 33 0.0007
237 PULMONARY VALVE INCOMPETENCE 1 0.0007
238 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
239 SLEEP PARALYSIS 1 0.0007
240 INFUSION SITE INDURATION 1 0.0007
241 AGE-RELATED MACULAR DEGENERATION 1 0.0007
242 HEAT STROKE 1 0.0007
243 MASTICATION DISORDER 2 0.0007
244 RUBBER SENSITIVITY 1 0.0007
245 CALCULUS URINARY 1 0.0006
246 COAGULATION TIME PROLONGED 1 0.0006
247 ILEUS 8 0.0006
248 MEGACOLON 1 0.0006
249 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
250 HALLUCINATION, AUDITORY 10 0.0006
251 UNRESPONSIVE TO STIMULI 16 0.0006
252 SKULL FRACTURE 1 0.0006
253 BREAST ENLARGEMENT 2 0.0006
254 COLONIC POLYP 1 0.0006
255 SEBORRHOEIC DERMATITIS 1 0.0006
256 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
257 PATHOLOGICAL GAMBLING 1 0.0006
258 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
259 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
260 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 1 0.0006
261 SLEEP TALKING 1 0.0006
262 NEUROPATHY 1 0.0006
263 ENTERITIS INFECTIOUS 1 0.0006
264 GAZE PALSY 1 0.0006
265 EYE MOVEMENT DISORDER 4 0.0006
266 MILIARIA 1 0.0006
267 HYPERTRANSAMINASAEMIA 4 0.0006
268 SPLENIC INFARCTION 1 0.0006
269 SUDDEN DEATH 6 0.0006
270 MACULOPATHY 2 0.0006
271 INTESTINAL OBSTRUCTION 21 0.0006
272 OBSESSIVE THOUGHTS 1 0.0006
273 HAEMATEMESIS 14 0.0006
274 RHABDOMYOLYSIS 23 0.0006
275 CEREBRAL VENOUS THROMBOSIS 1 0.0006
276 RESPIRATORY FAILURE 40 0.0005
277 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
278 PNEUMOPERITONEUM 1 0.0005
279 FREEZING PHENOMENON 2 0.0005
280 LOBAR PNEUMONIA 1 0.0005
281 URINARY RETENTION 18 0.0005
282 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
283 PERITONITIS 11 0.0005
284 JAUNDICE NEONATAL 1 0.0005
285 HYPOPROTEINAEMIA 1 0.0005
286 PANCREATIC CYST 1 0.0005
287 HALLUCINATION, VISUAL 11 0.0005
288 DYSKINESIA 21 0.0005
289 CONVERSION DISORDER 1 0.0005
290 PSYCHIATRIC DECOMPENSATION 1 0.0005
291 JOINT NOISE 1 0.0005
292 BRADYKINESIA 3 0.0005
293 POLYDIPSIA 2 0.0005
294 HALLUCINATION 38 0.0005
295 CEREBRAL ATROPHY 2 0.0005
296 PRODUCT ADMINISTRATION ERROR 10 0.0005
297 INTERNATIONAL NORMALISED RATIO DECREASED 2 0.0005
298 POLYURIA 4 0.0005
299 PSYCHOTIC SYMPTOM 1 0.0005
300 SUICIDAL BEHAVIOUR 2 0.0005
301 PHYSICAL ASSAULT 1 0.0005
302 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
303 SLEEP DEFICIT 1 0.0005
304 HEPATIC CYTOLYSIS 6 0.0005
305 RADIATION PNEUMONITIS 1 0.0005
306 INFUSION SITE BRUISING 1 0.0005
307 HYPERPROLACTINAEMIA 3 0.0005
308 LANGUAGE DISORDER 1 0.0005
309 TARDIVE DYSKINESIA 13 0.0005
310 TOOTH INJURY 2 0.0005
311 OLIGOMENORRHOEA 1 0.0005
312 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
313 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
314 ILEUS PARALYTIC 2 0.0004
315 LARGE INTESTINAL OBSTRUCTION 1 0.0004
316 HEPATOCELLULAR DAMAGE 1 0.0004
317 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
318 READING DISORDER 1 0.0004
319 MENOPAUSAL SYMPTOMS 1 0.0004
320 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
321 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 11 0.0004
322 SINUS TACHYCARDIA 6 0.0004
323 GASTROINTESTINAL OBSTRUCTION 1 0.0004
324 STARING 1 0.0004
325 PANNICULITIS 1 0.0004
326 INCORRECT DOSAGE ADMINISTERED 2 0.0004
327 GASTROINTESTINAL TUBE INSERTION 1 0.0004
328 TACHYARRHYTHMIA 1 0.0004
329 DRUG INTERACTION 63 0.0004
330 URINARY TRACT INFECTION BACTERIAL 1 0.0004
331 HYPOTHERMIA 4 0.0004
332 PARKINSON'S DISEASE 1 0.0004
333 INITIAL INSOMNIA 4 0.0004
334 DISSEMINATED TUBERCULOSIS 1 0.0004
335 DRUG ABUSE 32 0.0004
336 PSYCHOMOTOR SKILLS IMPAIRED 1 0.0004
337 NASAL DISORDER 1 0.0004
338 DELIRIUM 13 0.0004
339 BRUXISM 2 0.0004
340 MENTAL DISORDER 16 0.0004
341 ASPHYXIA 3 0.0004
342 GASTRIC PERFORATION 1 0.0004
343 STOMA SITE DISCHARGE 1 0.0004
344 SEROTONIN SYNDROME 7 0.0004
345 ACUTE RESPIRATORY FAILURE 7 0.0004
346 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
347 CHOKING 7 0.0004
348 ENDOTRACHEAL INTUBATION 1 0.0004
349 PSYCHOMOTOR RETARDATION 1 0.0004
350 INFUSION SITE ERYTHEMA 3 0.0004
351 STATUS EPILEPTICUS 4 0.0004
352 CEREBRAL THROMBOSIS 1 0.0004
353 VITAMIN B12 DECREASED 1 0.0003
354 ORTHOSTATIC HYPOTENSION 6 0.0003
355 STRESS CARDIOMYOPATHY 2 0.0003
356 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
357 STRIDOR 1 0.0003
358 HEPATITIS FULMINANT 1 0.0003
359 URINE ANALYSIS ABNORMAL 1 0.0003
360 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
361 THYROIDITIS 1 0.0003
362 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
363 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
364 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
365 MEDICAL DEVICE DISCOMFORT 1 0.0003
366 TALIPES 1 0.0003
367 EYELIDS PRURITUS 1 0.0003
368 INFUSION SITE SWELLING 2 0.0003
369 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
370 HEPATIC NEOPLASM 1 0.0003
371 LISTLESS 1 0.0003
372 NEAR DEATH EXPERIENCE 1 0.0003
373 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
374 BRADYCARDIA 16 0.0003
375 SKIN INJURY 1 0.0003
376 CYTOLYTIC HEPATITIS 1 0.0003
377 HYPOTONIA 3 0.0003
378 POTENTIATING DRUG INTERACTION 1 0.0003
379 AKATHISIA 4 0.0003
380 GASTRIC DISORDER 10 0.0003
381 DEPRESSION SUICIDAL 1 0.0003
382 HYPERREFLEXIA 1 0.0003
383 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
384 DEPRESSIVE SYMPTOM 1 0.0003
385 APPENDICECTOMY 1 0.0003
386 SEPTIC SHOCK 12 0.0003
387 MONOCYTE COUNT INCREASED 1 0.0003
388 DEVICE KINK 1 0.0003
389 ASPIRATION 3 0.0003
390 VENTRICULAR ARRHYTHMIA 1 0.0003
391 THROMBOCYTOSIS 1 0.0003
392 HYPOMANIA 1 0.0003
393 WOUND HAEMORRHAGE 1 0.0003
394 CEREBRAL DISORDER 2 0.0003
395 VENTRICULAR FIBRILLATION 3 0.0003
396 THROAT CLEARING 1 0.0003
397 DYSARTHRIA 10 0.0003
398 PROTEIN TOTAL DECREASED 1 0.0003
399 AUTOIMMUNE THYROIDITIS 1 0.0003
400 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
401 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
402 THYROID MASS 1 0.0003
403 PANIC DISORDER 1 0.0003
404 EJECTION FRACTION DECREASED 4 0.0003
405 ORAL INFECTION 1 0.0003
406 RESPIRATORY ACIDOSIS 1 0.0003
407 DYSPHAGIA 24 0.0003
408 EXPOSURE VIA BREAST MILK 1 0.0003
409 OBSTRUCTION 1 0.0003
410 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
411 BLEPHARITIS 1 0.0002
412 CANDIDIASIS 1 0.0002
413 MIOSIS 2 0.0002
414 DECUBITUS ULCER 2 0.0002
415 RECURRENT CANCER 1 0.0002
416 HYPERURICAEMIA 1 0.0002
417 EUGLYCAEMIC DIABETIC KETOACIDOSIS 1 0.0002
418 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
419 EOSINOPHIL COUNT INCREASED 2 0.0002
420 CONGESTIVE CARDIOMYOPATHY 1 0.0002
421 HALLUCINATIONS, MIXED 1 0.0002
422 CONFUSIONAL STATE 38 0.0002
423 AORTIC VALVE INCOMPETENCE 1 0.0002
424 INTENTIONAL OVERDOSE 15 0.0002
425 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
426 PARANOIA 4 0.0002
427 SEDATION 6 0.0002
428 EOSINOPHILIA 4 0.0002
429 DYSPHEMIA 1 0.0002
430 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
431 WHEELCHAIR USER 1 0.0002
432 TRANSAMINASES INCREASED 5 0.0002
433 THIRST 4 0.0002
434 LEUKOCYTOSIS 4 0.0002
435 VASCULAR DEVICE INFECTION 1 0.0002
436 AGITATION 16 0.0002
437 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
438 CARDIO-RESPIRATORY ARREST 9 0.0002
439 AGRANULOCYTOSIS 4 0.0002
440 BLOOD CHOLESTEROL INCREASED 10 0.0002
441 PERFORMANCE STATUS DECREASED 1 0.0002
442 CARPAL TUNNEL SYNDROME 3 0.0002
443 DEVICE OCCLUSION 3 0.0002
444 BLOOD PROLACTIN INCREASED 1 0.0002
445 SUBCUTANEOUS ABSCESS 1 0.0002
446 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
447 DIABETIC KETOACIDOSIS 5 0.0002
448 ATELECTASIS 2 0.0002
449 SINUS BRADYCARDIA 2 0.0002
450 CEREBROVASCULAR ACCIDENT 35 0.0002
451 TREMOR 34 0.0002
452 RENAL TUBULAR NECROSIS 2 0.0002
453 BODY TEMPERATURE DECREASED 2 0.0002
454 STAPHYLOCOCCAL SEPSIS 1 0.0002
455 FOOT OPERATION 1 0.0002
456 DISORIENTATION 8 0.0002
457 PRESCRIBED UNDERDOSE 4 0.0002
458 HYPERAMMONAEMIA 1 0.0002
459 LEUKOPENIA 10 0.0002
460 BRAIN INJURY 2 0.0002
461 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
462 INTENTIONAL SELF-INJURY 4 0.0002
463 KLEBSIELLA INFECTION 1 0.0002
464 DYSPHORIA 1 0.0002
465 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
466 BALANCE DISORDER 17 0.0002
467 SUBARACHNOID HAEMORRHAGE 2 0.0002
468 SLUGGISHNESS 2 0.0002
469 ENDOCARDITIS 1 0.0002
470 VARICOSE VEIN 1 0.0002
471 STOMACH DISCOMFORT 1 0.0002
472 VENTRICULAR EXTRASYSTOLES 2 0.0002
473 TENDERNESS 2 0.0002
474 APLASTIC ANAEMIA 1 0.0002
475 RESTLESSNESS 7 0.0002
476 SERUM FERRITIN INCREASED 1 0.0002
477 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
478 NYSTAGMUS 1 0.0002
479 PHARYNGOLARYNGEAL PAIN 1 0.0002
480 METABOLIC ACIDOSIS 6 0.0002
481 HEPATIC FUNCTION ABNORMAL 7 0.0002
482 HIP SURGERY 1 0.0002
483 ERYTHEMA OF EYELID 1 0.0002
484 SKIN LACERATION 2 0.0002
485 ACUTE KIDNEY INJURY 28 0.0002
486 AUTISM SPECTRUM DISORDER 1 0.0002
487 INTESTINAL ISCHAEMIA 1 0.0002
488 DRUG LEVEL INCREASED 3 0.0002
489 RASH MACULO-PAPULAR 4 0.0002
490 STREPTOCOCCAL INFECTION 1 0.0002
491 SOMNOLENCE 36 0.0002
492 PANCREATITIS ACUTE 4 0.0002
493 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
494 NEUTROPHILIA 1 0.0002
495 CARDIAC VALVE DISEASE 1 0.0002
496 MYOCARDITIS 2 0.0002
497 NEUTROPHIL COUNT DECREASED 7 0.0002
498 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
499 PRODUCT USE ISSUE 32 0.0002
500 ATAXIA 2 0.0002
501 HEPATITIS CHOLESTATIC 1 0.0002
502 HEPATITIS C 2 0.0002
503 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
504 PRE-EXISTING CONDITION IMPROVED 1 0.0002
505 SWELLING OF EYELID 1 0.0002
506 HEAD INJURY 5 0.0002
507 SLEEP APNOEA SYNDROME 3 0.0002
508 GALACTORRHOEA 1 0.0002
509 INFUSION SITE PAIN 2 0.0002
510 INCOHERENT 1 0.0002
511 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
512 BRADYPHRENIA 1 0.0002
513 GASTRITIS 4 0.0002
514 ABNORMAL BEHAVIOUR 6 0.0002
515 HAEMATOCRIT DECREASED 3 0.0002
516 TOXICITY TO VARIOUS AGENTS 25 0.0001
517 PULMONARY EMBOLISM 14 0.0001
518 FALL 49 0.0001
519 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
520 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
521 APPLICATION SITE RASH 2 0.0001
522 RESPIRATION ABNORMAL 1 0.0001
523 LARGE INTESTINE POLYP 1 0.0001
524 PANCYTOPENIA 8 0.0001
525 PAPULE 1 0.0001
526 LOSS OF CONSCIOUSNESS 18 0.0001
527 RED BLOOD CELL COUNT DECREASED 4 0.0001
528 CARDIOGENIC SHOCK 2 0.0001
529 HYPOKINESIA 2 0.0001
530 CONSTIPATION 30 0.0001
531 MOUTH HAEMORRHAGE 1 0.0001
532 DYSURIA 5 0.0001
533 PSYCHOTIC DISORDER 4 0.0001
534 TACHYCARDIA 12 0.0001
535 ARTHROPOD BITE 1 0.0001
536 FEELING DRUNK 1 0.0001
537 TROPONIN INCREASED 1 0.0001
538 HAEMODYNAMIC INSTABILITY 1 0.0001
539 HYPERTHERMIA 1 0.0001
540 EPILEPSY 4 0.0001
541 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
542 DEVICE RELATED INFECTION 2 0.0001
543 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
544 CONDITION AGGRAVATED 39 0.0001
545 THERAPY PARTIAL RESPONDER 2 0.0001
546 PULMONARY HAEMORRHAGE 1 0.0001
547 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
548 AFFECTIVE DISORDER 1 0.0001
549 BLOOD ALBUMIN DECREASED 1 0.0001
550 TRICUSPID VALVE INCOMPETENCE 1 0.0001
551 OBESITY 2 0.0001
552 MUSCLE TIGHTNESS 2 0.0001
553 CEREBRAL INFARCTION 3 0.0001
554 VENTRICULAR TACHYCARDIA 2 0.0001
555 MENSTRUAL DISORDER 1 0.0001
556 AGGRESSION 6 0.0001
557 BLOOD UREA INCREASED 2 0.0001
558 DRUG USE DISORDER 1 0.0001
559 CANDIDA INFECTION 2 0.0001
560 PSEUDOMONAS INFECTION 1 0.0001
561 MULTI-ORGAN FAILURE 2 0.0001
562 MUSCLE STRAIN 1 0.0001
563 PYELONEPHRITIS 1 0.0001
564 MUSCULOSKELETAL STIFFNESS 10 0.0001
565 HYPOXIA 4 0.0001
566 IMMUNOSUPPRESSION 1 0.0001
567 SEIZURE 13 0.0001
568 WRONG DRUG ADMINISTERED 1 0.0001
569 CARDIAC FAILURE 9 0.0001
570 MOBILITY DECREASED 8 0.0001
571 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
572 OEDEMA 6 0.0001
573 HYPERGLYCAEMIA 4 0.0001
574 HYPOTENSION 22 0.0001
575 IRON DEFICIENCY ANAEMIA 1 0.0001
576 HYPOKALAEMIA 5 0.0001
577 HEPATIC STEATOSIS 2 0.0001
578 THINKING ABNORMAL 2 0.0001
579 OVERDOSE 23 0.0001
580 HYPONATRAEMIA 6 0.0001
581 LACERATION 1 0.0001
582 EYE INFLAMMATION 1 0.0001
583 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
584 PRESCRIBED OVERDOSE 2 0.0001
585 HYPOGLYCAEMIA 5 0.0001
586 INFLAMMATORY BOWEL DISEASE 1 0.0001
587 THERAPY CHANGE 1 0.0001
588 URINARY INCONTINENCE 3 0.0001
589 OVARIAN CYST 1 0.0001
590 SPINAL FRACTURE 2 0.0001
591 TOXIC SKIN ERUPTION 1 0.0001
592 SUICIDE ATTEMPT 6 0.0001
593 NEUTROPHIL COUNT INCREASED 1 0.0001
594 EUPHORIC MOOD 1 0.0001
595 EMOTIONAL DISORDER 3 0.0001
596 EYE DISCHARGE 1 0.0001
597 SPEECH DISORDER 5 0.0001
598 INCONTINENCE 1 0.0001
599 RENAL FAILURE ACUTE 4 0.0001
600 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
601 PLATELET COUNT DECREASED 10 0.0001
602 POOR QUALITY SLEEP 2 0.0001
603 PHARYNGITIS STREPTOCOCCAL 1 0.0001
604 BIPOLAR DISORDER 1 0.0001
605 FOOT DEFORMITY 1 0.0001
606 TOOTH DISORDER 2 0.0001
607 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
608 SKIN INFECTION 1 0.0001
609 OCULAR DISCOMFORT 1 0.0001
610 MITRAL VALVE INCOMPETENCE 1 0.0001
611 DERMATITIS CONTACT 1 0.0001
612 ELECTROLYTE IMBALANCE 1 0.0001
613 COGNITIVE DISORDER 4 0.0001
614 COVID-19 PNEUMONIA 1 0.0001
615 ARRHYTHMIA 4 0.0001
616 BACTERAEMIA 1 0.0001
617 PRODUCT PRESCRIBING ERROR 2 0.0001
618 MYOCLONUS 1 0.0001
619 CEREBRAL HAEMORRHAGE 3 0.0001
620 HYPERLIPIDAEMIA 1 0.0001
621 POLYNEUROPATHY 1 0.0001
622 MENTAL IMPAIRMENT 2 0.0001
623 ADRENAL INSUFFICIENCY 1 0.0001
624 OFF LABEL USE 72 0.0001
625 CYTOPENIA 1 0.0001
626 RESPIRATORY DEPRESSION 1 0.0001
627 ENCEPHALOPATHY 2 0.0001
628 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
629 CARDIOMEGALY 1 0.0001
630 SMALL INTESTINAL OBSTRUCTION 1 0.0001
631 HYPERCALCAEMIA 1 0.0001
632 ABNORMAL WEIGHT GAIN 1 0.0001
633 INTENTIONAL PRODUCT MISUSE 7 0.0001
634 SECRETION DISCHARGE 1 0.0001
635 GAIT DISTURBANCE 15 0.0001
636 INTRAOCULAR PRESSURE INCREASED 1 0.0001
637 HYPOPHAGIA 2 0.0001
638 HEPATITIS 2 0.0001
639 MYDRIASIS 1 0.0001
640 SKIN ULCER 2 0.0001
641 DEEP VEIN THROMBOSIS 5 0.0001
642 AMNESIA 5 0.0001
643 PLATELET COUNT INCREASED 1 0.0001
644 IMMUNE SYSTEM DISORDER 1 0.0001
645 JOINT RANGE OF MOTION DECREASED 1 0.0001
646 DISTURBANCE IN ATTENTION 4 0.0001
647 NEUTROPENIA 10 0.0001
648 ACUTE HEPATIC FAILURE 1 0.0001
649 RESPIRATORY ARREST 2 0.0001
650 COORDINATION ABNORMAL 1 0.0001
651 DEMENTIA 2 0.0001
652 WITHDRAWAL SYNDROME 3 0.0001
653 BLOOD TEST ABNORMAL 1 0.0001
654 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
655 LYMPHOPENIA 1 0.0001
656 INTENTIONAL DOSE OMISSION 2 0.0001
657 CONVULSION 4 0.0001
658 HYPERHIDROSIS 9 0.0001
659 PARALYSIS 1 0.0001
660 IMPAIRED QUALITY OF LIFE 1 0.0001
661 NAUSEA 55 0.0001
662 MYELODYSPLASTIC SYNDROME 1 0.0001
663 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
664 DEVICE DISLOCATION 3 0.0001
665 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
666 GASTROENTERITIS 1 0.0001
667 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
668 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
669 INSOMNIA 18 0.0001
670 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
671 DEHYDRATION 9 0.0001
672 IMMUNODEFICIENCY 1 0.0001
673 ADVERSE DRUG REACTION 6 0.0001
674 ANXIETY 19 0.0001
675 BLOOD POTASSIUM DECREASED 2 0.0001
676 THERAPEUTIC RESPONSE DECREASED 4 0.0001
677 DRUG DISPENSING ERROR 1 0.0001
678 LIMB DISCOMFORT 2 0.0001
679 SWELLING 6 0.0001
680 DRUG-INDUCED LIVER INJURY 2 0.0001
681 CYANOSIS 1 0.0001
682 PRODUCT USE COMPLAINT 1 0.0001
683 OCULAR HYPERAEMIA 3 0.0001
684 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
685 RESPIRATORY TRACT CONGESTION 1 0.0001
686 SEPSIS 7 0.0001
687 MOOD SWINGS 2 0.0001
688 MOVEMENT DISORDER 2 0.0001
689 LACTIC ACIDOSIS 2 0.0001
690 BLOOD CREATININE INCREASED 4 0.0001
691 MANIA 1 0.0001
692 STAPHYLOCOCCAL INFECTION 2 0.0001
693 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
694 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
695 VISUAL ACUITY REDUCED 2 0.0001
696 TYPE 2 DIABETES MELLITUS 2 0.0001
697 NERVOUSNESS 3 0.0001
698 RASH MACULAR 2 0.0001
699 AMENORRHOEA 1 0.0001
700 DRUG WITHDRAWAL SYNDROME 5 0.0001
701 METASTASES TO LIVER 1 0.0001
702 DEPRESSED MOOD 3 0.0001
703 LYMPHOCYTE COUNT DECREASED 1 0.0001
704 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
705 THERAPY INTERRUPTED 4 0.0001
706 ASTHENIA 21 0.0001
707 DRUG EFFECT DECREASED 3 0.0001
708 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
709 C-REACTIVE PROTEIN INCREASED 2 0.0001
710 PYREXIA 19 0.0001
711 PANIC ATTACK 2 0.0001
712 TREATMENT NONCOMPLIANCE 3 0.0001
713 MEDICATION ERROR 3 0.0001
714 EYE SWELLING 2 0.0001
715 NECK PAIN 3 0.0001
716 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
717 UNEVALUABLE EVENT 4 0.0001
718 DEPRESSION 12 0.0001
719 NEUROPATHY PERIPHERAL 5 0.0001
720 MUSCULOSKELETAL DISORDER 1 0.0001
721 DIABETES MELLITUS 4 0.0001
722 MALAISE 23 0.0001
723 INCREASED APPETITE 1 0.0001
724 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
725 ORAL HERPES 1 0.0001
726 SURGERY 3 0.0001
727 VOMITING 24 0.0001
728 BLOOD PRESSURE ABNORMAL 1 0.0001
729 IRRITABILITY 3 0.0000
730 FEEDING DISORDER 1 0.0000
731 PLEURAL EFFUSION 3 0.0000
732 DRY MOUTH 4 0.0000
733 BONE MARROW FAILURE 1 0.0000
734 HAEMOGLOBIN DECREASED 5 0.0000
735 RIB FRACTURE 1 0.0000
736 PRODUCT USE IN UNAPPROVED INDICATION 12 0.0000
737 VISUAL IMPAIRMENT 6 0.0000
738 ABDOMINAL DISTENSION 5 0.0000
739 ROAD TRAFFIC ACCIDENT 2 0.0000
740 DERMATITIS 1 0.0000
741 MOUTH ULCERATION 1 0.0000
742 OSTEOARTHRITIS 2 0.0000
743 JOINT INJURY 1 0.0000
744 PNEUMONIA 15 0.0000
745 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
746 PRODUCT DISPENSING ERROR 1 0.0000
747 PRODUCT PRESCRIBING ISSUE 1 0.0000
748 HOSPITALISATION 7 0.0000
749 MELAENA 1 0.0000
750 BLOOD PRESSURE DECREASED 3 0.0000
751 STEVENS-JOHNSON SYNDROME 1 0.0000
752 ORAL PAIN 1 0.0000
753 GASTROINTESTINAL DISORDER 4 0.0000
754 RASH PAPULAR 1 0.0000
755 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
756 HEART RATE IRREGULAR 1 0.0000
757 MUSCULAR WEAKNESS 5 0.0000
758 SHOCK 1 0.0000
759 MUSCLE TWITCHING 1 0.0000
760 RENAL DISORDER 2 0.0000
761 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
762 SLEEP DISORDER 3 0.0000
763 BLOOD PRESSURE FLUCTUATION 1 0.0000
764 INTERSTITIAL LUNG DISEASE 2 0.0000
765 NEURALGIA 1 0.0000
766 UNDERDOSE 3 0.0000
767 LUNG DISORDER 2 0.0000
768 LIVER INJURY 1 0.0000
769 DYSPEPSIA 4 0.0000
770 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
771 DRY EYE 2 0.0000
772 SYNCOPE 4 0.0000
773 HOT FLUSH 3 0.0000
774 CELLULITIS 2 0.0000
775 ILLNESS 4 0.0000
776 INFLAMMATION 2 0.0000
777 EXPOSURE VIA SKIN CONTACT 1 0.0000
778 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
779 MUSCULOSKELETAL PAIN 2 0.0000
780 MUSCLE SPASMS 7 0.0000
781 DIARRHOEA 24 0.0000
782 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
783 MOOD ALTERED 1 0.0000
784 SKIN LESION 1 0.0000
785 INFLUENZA LIKE ILLNESS 3 0.0000
786 VISION BLURRED 5 0.0000
787 CARDIAC ARREST 3 0.0000
788 ABNORMAL DREAMS 1 0.0000
789 TREATMENT FAILURE 3 0.0000
790 MENTAL STATUS CHANGES 1 0.0000
791 FEELING COLD 1 0.0000
792 HAEMOPTYSIS 1 0.0000
793 WOUND 1 0.0000
794 RENAL IMPAIRMENT 3 0.0000
795 BLISTER 2 0.0000
796 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
797 HYPERSOMNIA 1 0.0000
798 EYE IRRITATION 2 0.0000
799 PANCREATIC CARCINOMA 1 0.0000
800 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
801 ABDOMINAL PAIN 8 0.0000
802 LIVER FUNCTION TEST ABNORMAL 1 0.0000
803 DYSSTASIA 1 0.0000
804 ACUTE MYOCARDIAL INFARCTION 1 0.0000
805 DEVICE ISSUE 3 0.0000
806 RESPIRATORY DISORDER 1 0.0000
807 HEPATIC FAILURE 1 0.0000
808 APHASIA 1 0.0000
809 CORONARY ARTERY DISEASE 1 0.0000
810 STOMATITIS 2 0.0000
811 ILL-DEFINED DISORDER 2 0.0000
812 VERTIGO 2 0.0000
813 SUICIDAL IDEATION 3 0.0000
814 INJECTION SITE RASH 1 0.0000
815 GYNAECOMASTIA 1 0.0000
816 FEMUR FRACTURE 1 0.0000
817 CARDIAC DISORDER 3 0.0000
818 CYSTITIS 1 0.0000
819 HYPOTHYROIDISM 1 0.0000
820 WEIGHT INCREASED 7 0.0000
821 HIP FRACTURE 1 0.0000
822 PRODUCT DOSE OMISSION ISSUE 9 0.0000
823 HEART RATE INCREASED 3 0.0000
824 RENAL FAILURE 4 0.0000
825 EXPIRED PRODUCT ADMINISTERED 1 0.0000
826 NEOPLASM MALIGNANT 2 0.0000
827 EYE PRURITUS 1 0.0000
828 ANGER 1 0.0000
829 FATIGUE 23 0.0000
830 HEPATIC ENZYME INCREASED 2 0.0000
831 URINARY TRACT INFECTION 5 0.0000
832 HAEMATURIA 1 0.0000
833 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
834 NIGHTMARE 1 0.0000
835 HYPERKALAEMIA 1 0.0000
836 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
837 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
838 CRYING 1 0.0000
839 ACCIDENTAL OVERDOSE 1 0.0000
840 NASOPHARYNGITIS 5 0.0000
841 HYPERSENSITIVITY 5 0.0000
842 THROMBOCYTOPENIA 3 0.0000
843 ASTHMA 3 0.0000
844 COLITIS 1 0.0000
845 CHRONIC KIDNEY DISEASE 2 0.0000
846 PERIPHERAL SWELLING 4 0.0000
847 PALPITATIONS 3 0.0000
848 ARTHRITIS 2 0.0000
849 DRUG INEFFECTIVE 33 0.0000
850 JOINT SWELLING 3 0.0000
851 EXTRA DOSE ADMINISTERED 1 0.0000
852 DEATH 21 0.0000
853 LUNG NEOPLASM MALIGNANT 1 0.0000
854 COMPLETED SUICIDE 2 0.0000
855 POLLAKIURIA 1 0.0000
856 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
857 HYPERTENSION 5 0.0000
858 MYALGIA 4 0.0000
859 RECTAL HAEMORRHAGE 1 0.0000
860 VAGINAL HAEMORRHAGE 1 0.0000
861 PULMONARY OEDEMA 1 0.0000
862 THROAT IRRITATION 1 0.0000
863 DIZZINESS 11 0.0000
864 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
865 MEMORY IMPAIRMENT 3 0.0000
866 NEPHROLITHIASIS 1 0.0000
867 SKIN DISCOLOURATION 1 0.0000
868 OROPHARYNGEAL PAIN 2 0.0000
869 CHEST PAIN 4 0.0000
870 ANAEMIA 4 0.0000
871 MIGRAINE 2 0.0000
872 RASH ERYTHEMATOUS 1 0.0000
873 MULTIPLE SCLEROSIS 1 0.0000
874 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
875 CONTUSION 2 0.0000
876 INFECTION 3 0.0000
877 ATRIAL FIBRILLATION 2 0.0000
878 HYPOAESTHESIA 3 0.0000
879 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
880 DYSPNOEA 11 0.0000
881 ECZEMA 1 0.0000
882 PARAESTHESIA 3 0.0000
883 PANCREATITIS 1 0.0000
884 RASH 8 0.0000
885 ANAPHYLACTIC REACTION 1 0.0000
886 WEIGHT DECREASED 5 0.0000
887 EYE PAIN 1 0.0000
888 FLATULENCE 1 0.0000
889 HERPES ZOSTER 1 0.0000
890 LETHARGY 1 0.0000
891 DECREASED APPETITE 4 0.0000
892 MYOCARDIAL INFARCTION 3 0.0000
893 COVID-19 3 0.0000
894 DYSPHONIA 1 0.0000
895 BONE PAIN 1 0.0000
896 CHILLS 2 0.0000
897 NASAL CONGESTION 1 0.0000
898 CATARACT 1 0.0000
899 FEELING ABNORMAL 4 0.0000
900 DISCOMFORT 1 0.0000
901 RHINORRHOEA 1 0.0000
902 SWELLING FACE 1 0.0000
903 PRODUCT DOSE OMISSION 1 0.0000
904 FEBRILE NEUTROPENIA 1 0.0000
905 SKIN BURNING SENSATION 1 0.0000
906 EPISTAXIS 1 0.0000
907 ACNE 1 0.0000
908 DRUG DEPENDENCE 2 0.0000
909 THROMBOSIS 1 0.0000
910 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
911 ARTHRALGIA 5 0.0000
912 ABDOMINAL DISCOMFORT 2 0.0000
913 SKIN EXFOLIATION 1 0.0000
914 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
915 ADVERSE EVENT 1 0.0000
916 PRURITUS 4 0.0000
917 DRUG INTOLERANCE 1 0.0000
918 CHEST DISCOMFORT 1 0.0000
919 ERYTHEMA 2 0.0000
920 ABDOMINAL PAIN UPPER 2 0.0000
921 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
922 HEADACHE 6 0.0000
923 HAEMORRHAGE 1 0.0000
924 INFLUENZA 1 0.0000
925 BACK PAIN 2 0.0000
926 EMOTIONAL DISTRESS 1 0.0000
927 OEDEMA PERIPHERAL 1 0.0000
928 PAIN 5 0.0000
929 COUGH 2 0.0000
930 BLOOD PRESSURE INCREASED 1 0.0000
931 INJECTION SITE PAIN 2 0.0000
932 DRUG DOSE OMISSION 1 0.0000
933 URTICARIA 1 0.0000
934 BLOOD GLUCOSE INCREASED 1 0.0000
935 ALOPECIA 1 0.0000
936 PAIN IN EXTREMITY 1 0.0000